Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition

Jianyu Liu,Minghai Tang,Tao Li,Zhengying Su,Zejiang Zhu,Caixia Dou,Yan Liu,Heying Pei,Jianhong Yang,Haoyu Ye,Lijuan Chen
DOI: https://doi.org/10.3389/fphar.2022.1000887
IF: 5.6
2022-09-27
Frontiers in Pharmacology
Abstract:[This corrects the article DOI: 10.3389/fphar.2022.811682.].
pharmacology & pharmacy
What problem does this paper attempt to address?